Exane Derivatives’s Coca-Cola Europacific Partners CCEP Stock Holding History

Exane Derivatives’s Portfolio CCEP Stock Details CCEP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$3.46K	Buy	67 +57	+570%	+$2.92K	﹤0.01%	405
2022 Q1	$486	Buy	+10	New	+$536	﹤0.01%	862
2021 Q2	–	Sell	-31	Closed	-$1.61K	–	1052
2021 Q1	$1.61K	Sell	31 -13,249	-100%	-$674K	﹤0.01%	697
2020 Q4	$636K	Buy	+13,280	New	+$561K	0.19%	115
2020 Q3	–	Sell	-48	Closed	-$1.81K	–	754
2020 Q2	$1.81K	Sell	48 -1,855	-97%	-$72.8K	﹤0.01%	511
2020 Q1	$71.4K	Sell	1,903 -13,895	-88%	-$675K	0.02%	322
2019 Q4	$811K	Buy	15,798 +15,792	+263,200%	+$832K	0.15%	115
2019 Q3	$335	Sell	6 -5,456	-100%	-$305K	﹤0.01%	611
2019 Q2	$308K	Buy	5,462 +1,055	+24%	+$57.6K	0.05%	215
2019 Q1	$228K	Sell	4,407 -773	-15%	-$36.7K	0.05%	209
2018 Q4	$237K	Buy	5,180 +2,636	+104%	+$122K	0.04%	229
2018 Q3	$115K	Buy	2,544 +2,541	+84,700%	+$108K	0.02%	304
2018 Q2	$122	Buy	+3	New	+$118	﹤0.01%	606

Other funds holding CCEP

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

Exane Derivatives's CCEP Position: Q2 2022 in Review

Exane Derivatives increased its Coca-Cola Europacific Partners (CCEP) stake by 570% in Q2 2022, buying an estimated $2.92K and bringing the position to 67 shares worth $3.46K. The position accounts for ﹤0.01% of the portfolio, ranked #405.

Exane Derivatives first reported a position in CCEP in Q2 2018 and has held it in 13 quarters since. The position peaked at $811K in Q4 2019. 362 funds tracked by Wall St. Rank hold CCEP as of Q2 2022.

Exane Derivatives held 67 shares of Coca-Cola Europacific Partners worth $3.46K as of Q2 2022.
Exane Derivatives bought 57 Coca-Cola Europacific Partners shares in Q2 2022, an estimated $2.92K.
Coca-Cola Europacific Partners made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #405 holding.
Exane Derivatives first reported a position in Coca-Cola Europacific Partners in Q2 2018 and has held it in 13 quarters since.
Exane Derivatives's Coca-Cola Europacific Partners position peaked at $811K in Q4 2019.
362 funds tracked by Wall St. Rank held Coca-Cola Europacific Partners as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.